Literature DB >> 28888558

Elimination of hepatitis C virus infection among PWID: The beginning of a new era of interferon-free DAA therapy.

Jason Grebely1, Julie Bruneau2, Philip Bruggmann3, Magdalena Harris4, Matthew Hickman5, Tim Rhodes6, Carla Treloar6.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28888558     DOI： 10.1016/j.drugpo.2017.08.001

Source DB:  PubMed          Journal:  Int J Drug Policy        ISSN： 0955-3959


× No keyword cloud information.
  20 in total

1.  Treatment cascade for hepatitis C virus in young adult people who inject drugs in San Francisco: Low number treated.

Authors:  Meghan D Morris; Ali Mirzazadeh; Jennifer L Evans; Alya Briceno; Phillip Coffin; Judith A Hahn; Kimberly A Page
Journal:  Drug Alcohol Depend       Date:  2019-02-27       Impact factor: 4.492

2.  Evaluation of contingency management as a strategy to improve HCV linkage to care and treatment in persons attending needle and syringe programs: A pilot study.

Authors:  B L Norton; M A Bachhuber; R Singh; L Agyemang; J H Arnsten; C O Cunningham; A H Litwin
Journal:  Int J Drug Policy       Date:  2019-04-16

3.  The use of all-oral direct-acting antivirals in hepatitis C virus-infected patients with substance use disorders.

Authors:  Xinyi Jiang; Hyun Jin Song; Wei Wang; Linda Henry; Lindsey M Childs-Kean; Vincent Lo Re; Haesuk Park
Journal:  J Manag Care Spec Pharm       Date:  2021-07

4.  Medical provider stigma experienced by people who use drugs (MPS-PWUD): Development and validation of a scale among people who currently inject drugs in New York City.

Authors:  Chunki Fong; Pedro Mateu-Gelabert; Courtney Ciervo; Benjamin Eckhardt; Yesenia Aponte-Melendez; Shashi Kapadia; Kristen Marks
Journal:  Drug Alcohol Depend       Date:  2021-02-13       Impact factor: 4.492

5.  "Stigma is where the harm comes from": Exploring expectations and lived experiences of hepatitis C virus post-treatment trajectories among people who inject drugs.

Authors:  Trevor Goodyear; Helen Brown; Annette J Browne; Peter Hoong; Lianping Ti; Rod Knight
Journal:  Int J Drug Policy       Date:  2021-04-23

6.  Barriers and facilitators to hepatitis C (HCV) screening and treatment-a description of prisoners' perspective.

Authors:  Des Crowley; Marie Claire Van Hout; John S Lambert; Enda Kelly; Carol Murphy; Walter Cullen
Journal:  Harm Reduct J       Date:  2018-12-11

7.  Hepatitis C virus screening and treatment in Irish prisons from nurse managers' perspectives - a qualitative exploration.

Authors:  D Crowley; M C Van Hout; C Murphy; E Kelly; J S Lambert; W Cullen
Journal:  BMC Nurs       Date:  2019-06-13

8.  Exploring how hospitalization can alter hepatitis c virus treatment prioritization and trajectories in people who use drugs: A qualitative analysis.

Authors:  Ximena A Levander; Taylor A Vega; Andrew Seaman; P Todd Korthuis; Honora Englander
Journal:  Subst Abus       Date:  2021-06-23       Impact factor: 3.716

9.  Cascade of Hepatitis C Virus Care Among Patients With Substance Use Disorders.

Authors:  Xinyi Jiang; Robert L Parker; Scott Martin Vouri; Weihsuan Lo-Ciganic; Vakaramoko Diaby; Linda Henry; Haesuk Park
Journal:  Am J Prev Med       Date:  2021-06-29       Impact factor: 6.604

10.  Pathways to ensure universal and affordable access to hepatitis C treatment.

Authors:  Caitlin H Douglass; Alisa Pedrana; Jeffrey V Lazarus; Ellen F M 't Hoen; Radi Hammad; Ricardo Baptista Leite; Andrew Hill; Margaret Hellard
Journal:  BMC Med       Date:  2018-10-09       Impact factor: 8.775
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.